Literature DB >> 808868

An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans.

K L Lee, H R Buckley, C C Campbell.   

Abstract

A chemically defined medium composed of 6 amino acids, biotin, inorganic salts and glucose for the growth of yeast and mycelial phases of Candida albicans at 25 degrees C and 37 degrees of C respectively was developed based on the aminopeptidase(s) profile of the fungus. This medium has proved successful in maintaining the growth characteristics of both phases during serial transfers. The relative pathogenicity, virulence, invasiveness and immunogenicity of the yeast and mycelial phases are discussed.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 808868     DOI： 10.1080/00362177585190271

Source DB:  PubMed          Journal:  Sabouraudia        ISSN： 0036-2174


  348 in total

1.  Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection.

Authors:  C Kvaal; S A Lachke; T Srikantha; K Daniels; J McCoy; D R Soll
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  HWP1 functions in the morphological development of Candida albicans downstream of EFG1, TUP1, and RBF1.

Authors:  L L Sharkey; M D McNemar; S M Saporito-Irwin; P S Sypherd; W A Fonzi
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

3.  Dominant active alleles of RIM101 (PRR2) bypass the pH restriction on filamentation of Candida albicans.

Authors:  A El Barkani; O Kurzai; W A Fonzi; A Ramon; A Porta; M Frosch; F A Mühlschlegel
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

4.  Transcription profiling of Candida albicans cells undergoing the yeast-to-hyphal transition.

Authors:  André Nantel; Daniel Dignard; Catherine Bachewich; Doreen Harcus; Anne Marcil; Anne-Pascale Bouin; Christoph W Sensen; Hervé Hogues; Marco van het Hoog; Paul Gordon; Tracey Rigby; François Benoit; Daniel C Tessier; David Y Thomas; Malcolm Whiteway
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

5.  E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis.

Authors:  Nao-Aki Watanabe; Mamiko Miyazaki; Takaaki Horii; Koji Sagane; Kappei Tsukahara; Katsura Hata
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

6.  Drug resistance is not directly affected by mating type locus zygosity in Candida albicans.

Authors:  Claude Pujol; Shawn A Messer; Michael Pfaller; David R Soll
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

7.  Characterization of cell wall proteins from yeast and mycelial cells of Candida albicans by labelling with biotin: comparison with other techniques.

Authors:  M Casanova; J L Lopez-Ribot; J P Martinez; R Sentandreu
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  APSES proteins regulate morphogenesis and metabolism in Candida albicans.

Authors:  Thomas Doedt; Shankarling Krishnamurthy; Dirk P Bockmühl; Bernd Tebarth; Christian Stempel; Claire L Russell; Alistair J P Brown; Joachim F Ernst
Journal:  Mol Biol Cell       Date:  2004-07       Impact factor: 4.138

9.  Fab fragments from a monoclonal antibody against a germ tube mannoprotein block the yeast-to-mycelium transition in Candida albicans.

Authors:  M Casanova; J P Martínez; W L Chaffin
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

10.  Factors influencing the expression in vitro of Candida albicans stress mannoproteins reactive with salivary secretory IgA.

Authors:  V Vidotto; L Polonelli; S Conti; J Pontón; I Vieta
Journal:  Mycopathologia       Date:  1998       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.